Unibest
← Back to patent-cliff list

CAS 103942-21-8

ethyl 2-(4-hydroxy-2-nitrophenoxy)acetate

Codes: RP-5063-003

Application context (from source-drug indications)

SchizophreniaBrilaroxazineMajor depressive disorderBrilaroxazinePulmonary arterial hypertensionBrilaroxazineIdiopathic pulmonary fibrosisBrilaroxazineManiaBrilaroxazineAttention deficit hyperactivity disorderBrilaroxazine

Source drugs (routes using this intermediate)

DrugTierExpiry
BrilaroxazineTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works1-(2,3-Dichlorophenyl)piperazine hydrochloride
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Siteethyl 2-(4-(4-(4-(2,3-dichlorophenyl)pipe
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Siteethyl 2-(4-(4-bromobutoxy)-2-nitrophenoxy)acetate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works3,3-dimethyldihydro-2H-pyran-2,6(3H)-dione
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Sitemethyl (R)-2-((tert-butoxycarbonyl)amino)-3-iodopropanoate
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site(S)-3-(5-bromo-1-ethyl-2-(2-(1-methoxyethyl)pyridin-3-yl)-1H-indol-3-yl)-2,2-dimethylpropan-1-ol
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.